2023
So You Want to be a Program Director? Career Paths of Colon and Rectal Surgery Residency Program Directors
Esposito A, Coppersmith N, Flom E, Chung M, Reddy V, Leeds I, Longo W, Pantel H, Yoo P, Mongiu A. So You Want to be a Program Director? Career Paths of Colon and Rectal Surgery Residency Program Directors. Journal Of Surgical Education 2023, 80: 588-596. PMID: 36658062, DOI: 10.1016/j.jsurg.2022.12.009.Peer-Reviewed Original Research
2022
Do Cultures From Percutaneously Drained Intra-abdominal Abscesses Change Treatment? A Retrospective Review
Esposito A, Zhang Y, Nagarkatti N, Laird W, Coppersmith N, Reddy V, Leeds I, Mongiu A, Longo W, Hao R, Pantel H. Do Cultures From Percutaneously Drained Intra-abdominal Abscesses Change Treatment? A Retrospective Review. Diseases Of The Colon & Rectum 2022, 66: 451-457. PMID: 36538708, DOI: 10.1097/dcr.0000000000002644.Peer-Reviewed Original ResearchConceptsIntra-abdominal abscessPercutaneous drainAntimicrobial therapyLos pacientesAbdominal abscessSingle university-affiliated institutionRetrospective medical record reviewEmpiric antibiotic regimensSolid organ transplantsMedical record reviewUniversity-affiliated institutionCulture dataAntibiotic coursesAbdominal infectionAntibiotic regimensActive smokersMedian ageActive chemotherapyRecord reviewEvidence-based practiceMedian lengthUtility of cultureFemale sexIntraoperative culturesInclusion criteria
2017
An Unusual Cause of Intestinal Perforation
Pernar LI, Mongiu A, Sheu EG. An Unusual Cause of Intestinal Perforation. JAMA Surgery 2017, 152: 199-200. PMID: 27926750, DOI: 10.1001/jamasurg.2016.4614.Peer-Reviewed Original Research
2010
Reconstruction of late‐onset transplant ureteral stricture disease
Helfand BT, Newman JP, Mongiu AK, Modi P, Meeks JJ, Gonzalez CM. Reconstruction of late‐onset transplant ureteral stricture disease. BJU International 2010, 107: 982-987. PMID: 20825404, DOI: 10.1111/j.1464-410x.2010.09559.x.Peer-Reviewed Original ResearchConceptsTransplant ureteral stricturesUreteral strictureGraft failureImmunosuppressive drug regimenKidney-pancreas transplantationStable allograft functionBaseline clinical characteristicsSerum creatinine levelsUrinary tract infectionLarge patient cohortUreteral stricture diseaseTime of reconstructionAllograft functionPostoperative complicationsRenal transplantationClinical characteristicsCreatinine levelsDrug regimenTract infectionsBalloon dilationMedian ageRepeat dilationStricture recurrenceSurgical managementOpen reconstruction
2009
Lower urinary tract symptoms, benign prostatic hyperplasia, and obesity
Mongiu AK, McVary KT. Lower urinary tract symptoms, benign prostatic hyperplasia, and obesity. Current Urology Reports 2009, 10: 247-253. PMID: 19570484, DOI: 10.1007/s11934-009-0041-8.Peer-Reviewed Original ResearchConceptsLower urinary tract symptomsBenign prostatic hyperplasiaBPH/lower urinary tract symptomsUrinary tract symptomsLifestyle modificationTract symptomsProstatic hyperplasiaGlobal public health challengeParticular polymorphismsCommon neoplastic conditionPrevalence of obesityClinical trial methodologyPublic health challengeStrong independent relationshipProstate sizePhysical inactivityTrial methodologyNeoplastic conditionsEpidemiological studiesObesityHealth challengesIndependent relationshipIndividual treatmentHyperplasiaSymptomsVariation in Institutional Review Board Responses to a Standard Protocol for a Multicenter Randomized, Controlled Surgical Trial
Helfand BT, Mongiu AK, Roehrborn CG, Donnell RF, Bruskewitz R, Kaplan SA, Kusek JW, Coombs L, McVary KT, Investigators M. Variation in Institutional Review Board Responses to a Standard Protocol for a Multicenter Randomized, Controlled Surgical Trial. Journal Of Urology 2009, 181: 2674-2679. PMID: 19375101, PMCID: PMC4720253, DOI: 10.1016/j.juro.2009.02.032.Peer-Reviewed Original ResearchConceptsInstitutional review boardStudy protocolSurgical trialsReview boardMulticenter trialLocal institutional review board reviewIdentical study protocolMulticenter surgical trialInstitutional review board approvalInvasive surgical therapiesBenign prostatic hyperplasiaMulticenter clinical trialReview board approvalSurgical therapyMedical therapyMulticenter RandomizedSurgical interventionProstatic hyperplasiaClinical trialsBoard approvalInstitutional review board reviewTrialsType of responseSecond reviewTherapyOutcomes of radical prostatectomy for patients with clinical stage T1a and T1b disease
Helfand BT, Mongiu AK, Kan D, Kim D, Loeb S, Roehl KA, Meeks JJ, Smith ND, Catalona WJ. Outcomes of radical prostatectomy for patients with clinical stage T1a and T1b disease. BJU International 2009, 104: 304-309. PMID: 19239451, DOI: 10.1111/j.1464-410x.2009.08421.x.Peer-Reviewed Original ResearchConceptsRadical retropubic prostatectomyClinical stage T1c diseaseStage T1c diseaseT1b diseaseT1c diseaseGleason scoreB diseasePathological featuresProstate cancerLower preoperative prostate-specific antigen levelsFavorable long-term functional outcomesPreoperative prostate-specific antigen levelLower cancer-specific survivalProstate-specific antigen levelLong-term functional outcomeClinical stage T1aStage T1b diseaseT1a/bT1b prostate cancerAdverse pathological featuresCancer-specific survivalOrgan-confined diseaseYear of surgeryOverall survival rateAggressive pathological features